Which selective serotonin reuptake inhibitor (SSRI) reduces hypersexuality?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Which SSRI Decreases Hypersexuality?

All SSRIs can decrease hypersexuality through their common side effect of sexual dysfunction, but paroxetine demonstrates the strongest effect for reducing sexual drive and delaying ejaculation, making it the most effective choice for managing hypersexuality. 1

Evidence-Based Reasoning

Paroxetine as First Choice

The AUA guidelines consistently identify paroxetine at 20 mg daily as providing the greatest benefit for sexual function suppression among SSRIs 1. Meta-analyses show paroxetine produces the strongest ejaculation delay, increasing ejaculatory latency time 8.8-fold over baseline 2. This robust effect on sexual function makes it the most reliable option for managing hypersexuality.

Dosing approach for paroxetine:

  • Start with 10-20 mg daily
  • Can increase to 40 mg daily if needed
  • Effects typically manifest within 1-2 weeks of daily dosing 1

Alternative SSRIs in Order of Potency

If paroxetine is not tolerated or contraindicated:

Second choice: Sertraline

  • Doses of 50-200 mg daily show significant sexual side effects
  • Higher doses increase efficacy for sexual suppression but also increase risk of erectile dysfunction and decreased libido 1
  • Start at 50 mg daily, titrate upward based on response

Third choice: Fluoxetine

  • Doses of 20-40 mg daily are effective
  • Has very long half-life, meaning side effects may persist for weeks after discontinuation 1
  • Start at 20 mg daily

Important Clinical Considerations

Sexual dysfunction profile varies by SSRI:

  • Paroxetine causes more delayed orgasm/ejaculation and erectile dysfunction than other SSRIs 3
  • Sertraline shows diverse sexual dysfunction manifestations 4
  • All SSRIs reduce libido, but paroxetine shows the most consistent effect 3, 5

Common pitfalls to avoid:

  • Do not use citalopram or fluvoxamine - these are specifically noted as ineffective for sexual function suppression 1
  • Avoid SSRIs in patients with bipolar disorder due to mania risk 2
  • Monitor for serotonin syndrome if combining with other serotonergic agents 1
  • Be aware that 58% of patients experience sexual dysfunction when directly asked, versus only 14% who spontaneously report it 3

Dosing strategy:

  • Daily dosing is more effective than on-demand dosing for sustained sexual suppression 1
  • Lower doses than those used for depression are often sufficient 1
  • Effects typically require ongoing treatment; sexual function usually returns upon discontinuation 1

Monitoring and Side Effects

Expected side effects include:

  • Decreased libido (desired effect in this context)
  • Delayed or absent orgasm
  • Erectile dysfunction in males
  • Nausea, dry mouth, drowsiness (typically mild at lower doses) 1

When to reassess: If no improvement in hypersexuality after 4 weeks at therapeutic doses, consider increasing dose or switching to a different SSRI with stronger sexual side effect profile.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.